6838 台新藥本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | -67.25 | 26.90 |
| 2026/04 | -69.75 | 27.90 |
| 2026/03 | -70.00 | 28.00 |
| 2026/02 | -70.38 | 28.15 |
| 2026/01 | -71.00 | 28.40 |
| 2025/12 | -66.00 | 26.40 |
| 2025/11 | -69.00 | 27.60 |
| 2025/10 | -70.25 | 28.10 |
| 2025/09 | -76.50 | 30.60 |
| 2025/08 | -80.13 | 32.05 |
| 2025/07 | -20.03 | 31.05 |
| 2025/06 | -23.81 | 36.90 |
| 2025/05 | -17.97 | 27.85 |
| 2025/04 | -18.04 | 25.80 |
| 2025/03 | -20.28 | 29.00 |
| 2025/02 | -24.83 | 35.50 |
| 2025/01 | -24.13 | 34.75 |
| 2024/12 | -26.01 | 37.45 |
| 2024/11 | -29.51 | 42.50 |
| 2024/10 | -18.72 | 42.50 |
| 2024/09 | -21.26 | 48.25 |
| 2024/08 | -17.60 | 39.95 |
| 2024/07 | - | - |
| 2024/06 | - | - |
| 2024/05 | - | - |
| 2024/04 | - | - |
| 2024/03 | - | - |
| 2024/02 | - | - |
| 2024/01 | - | - |
| 2023/12 | - | - |
| 2023/11 | - | - |
| 2023/10 | - | - |
| 2023/09 | - | - |
| 2023/08 | - | - |
| 2023/07 | - | - |
| 2023/06 | - | - |
| 2023/05 | - | - |
| 2023/04 | - | - |
| 2023/03 | - | - |
| 2023/02 | - | - |
| 2023/01 | - | - |
| 2022/12 | - | - |
| 2022/11 | - | - |
| 2022/10 | - | - |
| 2022/09 | - | - |
| 2022/08 | - | - |
| 2022/07 | - | - |
| 2022/06 | - | - |
| 2022/05 | - | - |
| 2022/04 | - | - |
| 2022/03 | - | - |
| 2022/02 | - | - |
| 2022/01 | - | - |
| 2021/12 | - | - |
| 2021/11 | - | - |
| 2021/10 | - | - |
| 2021/09 | - | - |
| 2021/08 | - | - |
| 2021/07 | - | - |
| 2021/06 | - | - |
| 2021/05 | - | - |
| 2021/04 | - | - |
| 2021/03 | - | - |
| 2021/02 | - | - |
| 2021/01 | - | - |